Who owns the NOVELSTAR PHARMACEUTICALS INC. trademark?

The NOVELSTAR PHARMACEUTICALS INC. trademark is owned by Novelstar Pharmaceuticals Inc..

What class is the NOVELSTAR PHARMACEUTICALS INC. trademark registered in?

The NOVELSTAR PHARMACEUTICALS INC. trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for NOVELSTAR PHARMACEUTICALS INC.?

The USPTO serial number for NOVELSTAR PHARMACEUTICALS INC. is 88977122.

What is the registration number for NOVELSTAR PHARMACEUTICALS INC.?

NOVELSTAR PHARMACEUTICALS INC. is registered under USPTO registration number 6049797.

NOV

USPTO Trademark Record

REGISTERED

NOVELSTAR PHARMACEUTICALS INC.

SN 88977122·Reg 6049797·Filed Jun 27, 2018

Owner Novelstar Pharmaceuticals Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

NOVELSTAR PHARMACEUTICALS INC. (Serial No. 88977122), Registration No. 6049797, is a registered US trademark filed on Jun 27, 2018 by Novelstar Pharmaceuticals Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

renewal grace 6y period: November 05, 202631 days remaining

Mark Intelligence

NOVELSTAR PHARMACEUTICALS INC. (Reg. #6049797) is a registered US trademark that has been protecting its owner, Novelstar Pharmaceuticals Inc., since 2018. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 27, 2018

SERIAL

88977122

REG#

6049797

REGISTERED

May 05, 2020

Owner

Applicant

Novelstar Pharmaceuticals Inc.

Entity

Corporation

State

Address

2005 Eastpark Blvd, Cranbury, NJ, 08512

Country

Attorney

NameMichael J. Leonard

Law firm

Michael J. Leonard Fox Rothschild LLP

Docket

186181.00003

Address

997 Lenox Drive, Bldg. 3, Lawrenceville, NJ 08648-2311, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 27, 2018

Serial Number88977122

Registration No.6049797

Registration DateMay 05, 2020

Status DateMay 05, 2020

Published for OppositionJun 25, 2019

Mark TypeStandard characters

Attorney Docket186181.00003

Status DescriptionLive and registered

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 31, 2018

First use in commerce: Aug 31, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 05, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

May 05, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 28, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 27, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 16, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

DIVISIONAL PROCESSING COMPLETE

Mar 16, 2020

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Mar 16, 2020

STATEMENT OF USE PROCESSING COMPLETE

DIVISIONAL REQUEST RECEIVED

Feb 13, 2020

DIVISIONAL REQUEST RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Feb 13, 2020

TEAS REQUEST TO DIVIDE RECEIVED

TEAS STATEMENT OF USE RECEIVED

Feb 13, 2020

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Feb 13, 2020

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 20, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 25, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 25, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 05, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

May 16, 2019

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

May 01, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 08, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 07, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 07, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 01, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 01, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 11, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 11, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 23, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Oct 23, 2018

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Oct 23, 2018

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Oct 18, 2018

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 01, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 30, 2018

NEW APPLICATION ENTERED

NOVELSTAR PHARMACEUTICALS INC.

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Novelstar Pharmaceuticals Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Michael J. Leonard

Resources

Company